Flavivirus NS1 protein in infected host sera enhances viral acquisition by mosquitoes

Nature Microbiology

Volumn 1, Issue 9, 2016, Pages

  Liu, Jianying ^a   Liu, Yang ^a,b,c   Nie, Kaixiao ^a   Du, Senyan ^a   Qiu, Jingjun ^d   Pang, Xiaojing ^a   Wang, Penghua ^e   Cheng, Gong ^a,b  

^a Tsinghua University   (China)

^b SOUTHERN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^c TSINGHUA UNIVERSITY   (China)

^d FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^e NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON RECEPTOR; NS1 PROTEIN, FLAVIVIRUS; VIRAL PROTEIN;

ANIMAL; BLOOD; C57BL MOUSE; CELL LINE; DENGUE VIRUS; DROSOPHILA; FEMALE; FLAVIVIRUS; FLAVIVIRUS INFECTION; GENETICS; GERMFREE ANIMAL; HUMAN; IMMUNOLOGY; JAPANESE ENCEPHALITIS VIRUS; MALE; METABOLISM; MOSQUITO; MOUSE; TRANSMISSION; VIRION; VIROLOGY;

ANIMALS; CELL LINE; CULICIDAE; DENGUE VIRUS; DROSOPHILA; ENCEPHALITIS VIRUS, JAPANESE; FEMALE; FLAVIVIRUS; FLAVIVIRUS INFECTIONS; HUMANS; MALE; MICE; MICE, INBRED C57BL; RECEPTORS, INTERFERON; SPECIFIC PATHOGEN-FREE ORGANISMS; VIRAL NONSTRUCTURAL PROTEINS; VIRION;

EID: 84983628458     PISSN: None     EISSN: 20585276     Source Type: Journal    
DOI: 10.1038/nmicrobiol.2016.87     Document Type: Article

References (46)

1. Gould, E. A. & Solomon, T. Pathogenic flaviviruses. Lancet 371, 500-509 (2008).
2. Rigau-Perez, J. G. et al. Dengue and dengue haemorrhagic fever. Lancet 352, 971-977 (1998).
3. Bhatt, S. et al. The global distribution and burden of dengue. Nature 496, 504-507 (2013).
4. Campbell, G. L. et al. Estimated global incidence of Japanese encephalitis: a systematic review. Bull. World Health Organ. 89, 766-774 (2011).
5. Muller, D. A. & Young, P. R. The flavivirus NS1 protein: molecular and structural biology, immunology, role in pathogenesis and application as a diagnostic biomarker. Antiviral Res. 98, 192-208 (2013).
6. Akey, D. L. et al. Flavivirus NS1 structures reveal surfaces for associations with membranes and the immune system. Science 343, 881-885 (2014).
7. Young, P. R., Hilditch, P. A., Bletchly, C. & Halloran, W. An antigen capture enzyme-linked immunosorbent assay reveals high levels of the dengue virus protein NS1 in the sera of infected patients. J. Clin. Microbiol. 38, 1053-1057 (2000).
8. Alcon, S. et al. Enzyme-linked immunosorbent assay specific to dengue virus type 1 nonstructural protein NS1 reveals circulation of the antigen in the blood during the acute phase of disease in patients experiencing primary or secondary infections. J. Clin. Microbiol. 40, 376-381 (2002).
9. Beatty, P. R. et al. Dengue virus NS1 triggers endothelial permeability and vascular leak that is prevented by NS1 vaccination. Sci. Transl. Med. 7, 304ra141 (2015).
10. Modhiran, N. et al. Dengue virus NS1 protein activates cells via Toll-like receptor 4 and disrupts endothelial cell monolayer integrity. Sci. Transl. Med. 7, 304ra142 (2015).
11. Avirutnan, P. et al. Antagonism of the complement component C4 by flavivirus nonstructural protein NS1. J. Exp. Med. 207, 793-806 (2010).
12. Schlesinger, J. J., Brandriss, M. W. & Walsh, E. E. Protection of mice against dengue 2 virus encephalitis by immunization with the dengue 2 virus nonstructural glycoprotein NS1. J. Gen. Virol. 68, 853-857 (1987).
13. Lin, C. F. et al. Expression of cytokine, chemokine, and adhesion molecules during endothelial cell activation induced by antibodies against dengue virus nonstructural protein 1. J. Immunol. 174, 395-403 (2005).
14. Liu, I. J., Chiu, C. Y., Chen, Y. C. & Wu, H. C. Molecular mimicry of human endothelial cell antigen by autoantibodies to nonstructural protein 1 of dengue virus. J. Biol. Chem. 286, 9726-9736 (2011).
15. Omokoko, M. D. et al. A highly conserved region between amino acids 221 and 266 of dengue virus non-structural protein 1 is a major epitope region in infected patients. Am. J. Trop. Med. Hyg. 91, 146-155 (2014).
16. Cheng, H. J. et al. Anti-dengue virus nonstructural protein 1 antibodies recognize protein disulfide isomerase on platelets and inhibit platelet aggregation. Mol. Immunol. 47, 398-406 (2009).
17. Liu, Y. et al. Transmission-blocking antibodies against mosquito C-type lectins for dengue prevention. PLoS Pathogens 10, e1003931 (2014).
18. Cheng, G., Liu, Y., Wang, P. & Xiao, X. Mosquito defense strategies against viral infection. Trends Parasitol. 32, 177-186 (2016).
19. Chung, K. M. & Diamond, M. S. Defining the levels of secreted non-structural protein NS1 afterWest Nile virus infection in cell culture and mice. J. Med. Virol. 80, 547-556 (2008).
20. Tan, G. K. et al. A non mouse-adapted dengue virus strain as a new model of severe dengue infection in AG129 mice. PLoS Negl. Trop. Dis. 4, e672 (2010).
21. Orozco, S. et al. Characterization of a model of lethal dengue virus 2 infection in C57BL/6 mice deficient in the alpha/beta interferon receptor. J. Gen. Virol. 93, 2152-2157 (2012).
22. Halstead, S. B. Dengue. Lancet 370, 1644-1652 (2007).
23. Guo, X. X. et al. Vector competence of Aedes albopictus and Aedes aegypti (Diptera: Culicidae) for DEN2-43 and New Guinea C virus strains of dengue 2 virus. Acta Trop. 128, 566-570 (2013).
24. Sang, S. et al. Predicting unprecedented dengue outbreak using imported cases and climatic factors in Guangzhou, 2014. PLoS Negl. Trop. Dis. 9, e0003808 (2015).
25. Takamatsu, Y. et al. NS1? protein expression facilitates production of Japanese encephalitis virus in avian cells and embryonated chicken eggs. J. Gen. Virol. 95, 373-383 (2014).
26. Xi, Z., Ramirez, J. L. & Dimopoulos, G. The Aedes aegypti toll pathway controls dengue virus infection. PLoS Pathogens 4, e1000098 (2008).
27. Sánchez-Vargas, I. et al. Dengue virus type 2 infections of Aedes aegypti are modulated by the mosquito's RNA interference pathway. PLoS Pathogens 5, e1000299 (2009).
28. Souza-Neto, J. A., Sim, S. & Dimopoulos, G. An evolutionary conserved function of the JAK-STAT pathway in anti-dengue defense. Proc. Natl Acad. Sci. USA 106, 17841-17846 (2009).
29. Carissimo, G. et al. Antiviral immunity of Anopheles gambiae is highly compartmentalized, with distinct roles for RNA interference and gut microbiota. Proc. Natl Acad. Sci. USA 112, E176-E185 (2015).
30. Cirimotich, C. M. et al. Natural microbe-mediated refractoriness to Plasmodium infection in Anopheles gambiae. Science 332, 855-858 (2011).
31. Lee, K. A. et al. Bacterial-derived uracil as a modulator of mucosal immunity and gut-microbe homeostasis in Drosophila. Cell 153, 797-811 (2013).
32. Dostert, C. et al. The Jak-STAT signaling pathway is required but not sufficient for the antiviral response of Drosophila. Nature Immunol. 6, 946-953 (2005).
33. The malERA Consultative Group on Vaccines. A research agenda for malaria eradication: vaccines. PLoS Med. 8, e1000398 (2011).
34. Falconar, A. K. The dengue virus nonstructural-1 protein (NS1) generates antibodies to common epitopes on human blood clotting, integrin/adhesin proteins and binds to human endothelial cells: potential implications in haemorrhagic fever pathogenesis. Arch. Virol. 142, 897-916 (1997).
35. Calvert, A. E., Huang, C. Y., Kinney, R. M. & Roehrig, J. T. Non-structural proteins of dengue 2 virus offer limited protection to interferon-deficient mice after dengue 2 virus challenge. J. Gen. Virol. 87, 339-346 (2006).
36. Amorim, J. H. et al. Protective immunity to DENV2 after immunization with a recombinant NS1 protein using a genetically detoxified heat-labile toxin as an adjuvant. Vaccine 30, 837-845 (2012).
37. Pan, X. et al. Wolbachia induces reactive oxygen species (ROS)-dependent activation of the Toll pathway to control dengue virus in the mosquito Aedes aegypti. Proc. Natl Acad. Sci. USA 109, E23-E31 (2012).
38. Cheng, G. et al. A C-type lectin collaborates with a CD45 phosphatase homolog to facilitate West Nile virus infection of mosquitoes. Cell 142, 714-725 (2010).
39. Londono-Renteria, B. et al. Dengue virus infection of Aedes aegypti requires a putative cysteine rich venom protein. PLoS Pathogens 11, e1005202 (2015).
40. Miura, K. et al. Transmission-blocking activity induced by malaria vaccine candidates Pfs25/Pvs25 is a direct and predictable function of antibody titer. Malaria J. 6, 107 (2007).
41. Chowdhury, D. R., Angov, E., Kariuki, T. & Kumar, N. A potent malaria transmission blocking vaccine based on codon harmonized full length Pfs48/45 expressed in Escherichia coli. PLoS ONE 4, e6352 (2009).
42. Bai, F. et al. Antiviral peptides targeting the West Nile virus envelope protein. J. Virol. 81, 2047-2055 (2007).
43. Falconar, A. K. & Young, P. R. Immunoaffinity purification of the native dimer forms of the flavivirus non-structural protein, NS1. J. Virol. Methods 30, 323-332 (1990).
44. Cepko, C. Large-scale preparation and concentration of retrovirus stocks. Curr. Protoc. Mol. Biol. 9, 9. 12. 1-9. 12. 6 (2001).
45. Estridge, B. H., Reynolds, A. P. & Walters, N. J. Basic Medical Laboratory Techniques Ch. 2 (Cengage Learning, 2000).
46. Graham, J. Isolation of human platelets (thrombocytes). Sci. World J. 2, 1607-1609 (2002).